First Time Loading...
T

Teva Pharmaceutical Industries Ltd
NYSE:TEVA

Watchlist Manager
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Watchlist
Price: 16.45 USD 2.81%
Updated: May 10, 2024

Gross Margin
Teva Pharmaceutical Industries Ltd

50.3%
Current
49%
Average
49.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
50.3%
=
Gross Profit
8B
/
Revenue
15.8B

Gross Margin Across Competitors

Country IL
Market Cap 66.1B ILS
Gross Margin
50%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 725.7B USD
Gross Margin
80%
Country DK
Market Cap 3.9T DKK
Gross Margin
85%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country US
Market Cap 359.6B USD
Gross Margin
70%
Country US
Market Cap 330B USD
Gross Margin
75%
Country UK
Market Cap 191.8B GBP
Gross Margin
82%
Country CH
Market Cap 179.5B CHF
Gross Margin
73%
Country CH
Market Cap 180.6B CHF
Gross Margin
74%
Country US
Market Cap 158B USD
Gross Margin
70%

Profitability Report

View the profitability report to see the full profitability analysis for Teva Pharmaceutical Industries Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
50.3%
=
Gross Profit
8B
/
Revenue
15.8B
What is the Gross Margin of Teva Pharmaceutical Industries Ltd?

Based on Teva Pharmaceutical Industries Ltd's most recent financial statements, the company has Gross Margin of 50.3%.